The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 28 | 30.6x | 20.1x | Below average | |
Growth | 90 | 51.2% | 5.6% | Above average | |
Quality | 74 | 9.8% | 7.6% | Above average | |
Safety | 58 | -1.4x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Ligand Pharmaceuticals Incorporated is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Ligand Pharmaceuticals Incorporated shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Ligand stock shows complete stability in price targets over the past 30 days, with the average price target stabilizing at 267.75 dollars, reflecting a price premium of 16.7% over the current price of 229.33 dollars. We note a narrowing in the analyst dispersion range between a low of 252 and a high of 289, indicating high consensus on the stock's fair value despite the limited number of analysts participating in the current coverage.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.